MedPath

Role of the Sympathetic Nervous System in Rosacea

Not Applicable
Recruiting
Conditions
Rosacea
Interventions
Other: systemic and local stressors
Registration Number
NCT03989492
Lead Sponsor
Indiana University
Brief Summary

Rosacea is a common skin disorder which causes facial redness and inflammation in about 16 million Americans, from an unknown cause. Many triggers of rosacea symptoms are stressors that affect the sympathetic ("fight or flight") portion of the nervous system, and a recent pilot study suggests there is sympathetic dysfunction in rosacea. This project will benefit patients, clinicians, and basic scientists by increasing our understanding of sympathetic nervous system involvement in rosacea symptoms in order to develop improved treatments for patients with rosacea.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
210
Inclusion Criteria
  • Otherwise healthy males and non-pregnant/non-lactating females with mild to moderate erythematotelangiectactic rosacea, as well as age-sex matched healthy control subjects.
Read More
Exclusion Criteria
  • Neurological, cardiovascular, respiratory, metabolic, muscular, or other dermatological disorders
  • Current history of alcohol and/or drug abuse
  • Known allergies or hypersensitivities to medications/drugs that are used in the protocol
  • Current smoking or regular smoking within the last 2 years
  • Body mass index > 35 kg/m2
  • Medications or supplements which are known to affect neural, cardiovascular, or muscular responses
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Autonomic responses to stressorssystemic and local stressorsProtocol 1: mental math and handgrip exercise. Protocol 2: systemic stressors and end-organ receptor stimulation. Protocol 3: local heating.
Primary Outcome Measures
NameTimeMethod
Skin sympathetic nerve activityImmediate (during the single-day study). This study consists of a one-day protocol, during which this outcome is measured.

microneurography

Skin blood flowImmediate (during the single-day study). This study consists of a one-day protocol, during which this outcome is measured.

laser Doppler flowmetry

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

Indiana University

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath